Welcome to our dedicated page for Carecloud SEC filings (Ticker: CCLD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CareCloud, Inc. filings document operating results, Regulation FD presentation materials, governance actions, and capital-structure disclosures for a healthcare technology and revenue cycle management company. The records cover common stock, preferred-stock dividend and security matters, credit facility events, and formal updates tied to financial performance.
CareCloud’s proxy and current reports also disclose shareholder voting matters, bylaw amendments, board and audit committee composition, Nasdaq compliance items, and cybersecurity incident reporting. These filings frame the company’s Healthcare IT and Medical Practice Management activities alongside risk, governance, and public-company reporting obligations.
CareCloud, Inc. entered into a new Credit Agreement providing a $40 million term loan and a $10 million revolving credit facility maturing on the fourth anniversary of closing. The loans are secured by substantially all company and subsidiary assets and carry interest based on SOFR or an alternate base rate plus a margin.
As part of the collateral package, Executive Chairman Mahmud Haq will pledge certain securities accounts and receive a five-year warrant exercisable for 4,300,000 common shares at $5.00 per share. The company also put in place an at-the-market equity program to sell up to $60 million of common stock through Citizens JMP Securities.
CareCloud elected to redeem all 1,511,372 outstanding shares of its 8.75% Series B Preferred Stock on May 15, 2026 at $25.25 per share plus $2.27 of accrued dividends, for total cash of $27.52 per share. The redemption is expected to eliminate approximately $3.2 million in annual preferred dividends; management notes the company generates about $30 million in annualized adjusted EBITDA.
CareCloud, Inc. is asking shareholders to vote at its June 4, 2026 annual meeting on director elections, executive pay, a new 2026 Equity Incentive Plan, and ratification of Tanner LLP as auditor for 2026.
The proxy describes governance structures, board and committee activity, and detailed director and executive compensation, including 2025 salaries such as $300,000 for Executive Chairman Mahmud Haq and co-CEOs. It also outlines related-party arrangements, including leases with the Executive Chairman and consulting agreements with family members and a director-controlled entity. The new 2026 Equity Incentive Plan would authorize up to 1,000,000 shares for future equity awards alongside existing plan reserves.
CareCloud, Inc. filed a current report describing a change to its corporate bylaws. On April 2, 2026, the Board of Directors approved and adopted Amended and Restated Bylaws, effective immediately, revising the quorum requirement for meetings of stockholders. The full text of the amended bylaws is provided as an exhibit to the report.
CareCloud, Inc. reported a board change affecting its audit committee. On March 24, 2026, the board appointed Cameron Munter to serve as a member of the Audit Committee. The board determined he meets Nasdaq’s independence requirements, so the Audit Committee now has three independent directors and the company has regained compliance with Nasdaq Listing Rule 5605(c)(2). Nasdaq has notified the company that it is back in compliance with this rule.
CareCloud, Inc. reports a material cybersecurity incident involving its CareCloud Health division. On March 16, 2026, a temporary network disruption affected 1 of its 6 electronic health record environments for about eight hours until functionality and data access were fully restored that evening.
The incident, believed to be caused by an unauthorized third party, appears contained to the CareCloud Health environment. CareCloud engaged a Big Four cyber response team, notified its cybersecurity insurer, and reported the matter to law enforcement. The company is still determining whether, and to what extent, patient information or other data was accessed or exfiltrated.
CareCloud states that, as of this report, the incident has not had a material impact on operations and is not reasonably likely to have a material impact on its financial condition or results of operations. It nevertheless deems the incident material due to the sensitivity of potentially affected data and potential remediation, legal, regulatory, notification, and reputational consequences.
CareCloud, Inc. files its annual report describing its technology-enabled revenue cycle management, cloud software and expanding generative AI solutions for U.S. healthcare providers. The company relies heavily on offshore operations in Pakistan and Sri Lanka, where roughly 3,300 staff support its cost advantage.
As of June 30, 2025, non‑affiliate common equity had an aggregate market value of about $85.1 million, and at March 6, 2026 there were 42,492,949 common shares outstanding. The filing highlights extensive business, cybersecurity, regulatory and macro risks, including past suspension and later resumption of preferred dividends, ongoing arrears, and dilution from a March 2025 conversion of most Series A preferred into common stock.
CareCloud, Inc. filed a current report describing several updates. The company issued an earnings press release and an accompanying slide presentation on March 12, 2026, which are included as exhibits and provide details on its recent operating and financial performance.
On March 10, 2026, director A. Hadi Chaudhry resigned from the Board, effective immediately. His resignation is intended to help the company regain compliance with Nasdaq Listing Rule 5605, which requires a majority-independent board. The company states his departure did not arise from any disagreement over operations, policies, or practices.
CareCloud director Lawrence S. Sharnak reported an equity award vesting and share issuance. On February 8, 2026, 7,500 restricted stock units converted into 7,500 shares of CareCloud common stock at a price of $0. According to the filing, these restricted stock units and the resulting shares were granted under the company’s Amended and Restated Equity Incentive Plan without payment by Sharnak.
Following the transaction, Sharnak directly owned 127,750 shares of common stock and 26,250 restricted stock units. This reflects routine compensation-related activity rather than an open-market purchase or sale.
CareCloud, Inc. director Cameron Munter reported a routine equity compensation vesting. On February 8, 2026, 7,500 restricted stock units converted into 7,500 shares of common stock at a price of $0 per share, under the company’s Amended and Restated Equity Incentive Plan.
After this conversion, Munter directly beneficially owned 202,750 shares of CareCloud common stock and 26,250 restricted stock units. The transaction involved no cash payment by the reporting person and reflects standard compensation-based vesting rather than an open‑market purchase or sale.
CareCloud, Inc. director Anne Busquet reported the vesting and conversion of 7,500 restricted stock units into common stock on February 8, 2026. The RSUs and resulting shares were issued under the company’s Amended and Restated Equity Incentive Plan without any cash payment by her.
After this equity award vesting, she directly holds 295,138 shares of CareCloud common stock and 26,250 derivative securities in the form of restricted stock units.